This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mok, C C Articles by Lau, C S Search for Related Content PubMed PubMed Citation Articles by Mok, C C Articles by Lau, C S Pubmed/NCBI databases Medline Plus Health Information Lupus Social Bookmarking                         What's this?

Lupus in Hong Kong Chinese

Department of Medicine, Tuen Mun Hospital, Hong Kong Special Administrative Region, China, ccmok{at}netvigator.com

C S Lau

University Department of Medicine, Queen Mary Hospital, Hong Kong, Special Administrative Region, China

Systemic lupus erythematosus (SLE) is a fairly common rheumatic disease among southern Chinese in Hong Kong, with an estimated point prevalence of 0.06% (0.1% among women). Compared with the Caucasians, renal disease and the anti-Ro antibody appear to be more common in our SLE patients. Whether these are related to certain genetic or environment factors remains speculative. Nephritis and its treatment are the major causes of organ damage in our lupus population. With early diagnosis of the disease and its complications, judicious use of immunosuppressive therapy to achieve prompt control of disease activity, and better supportive care for disease-or treatment-related morbidity, the survival of our Chinese SLE patients has improved. In the past decade, considerable effort has been spent on lupus education, medical training and research in Hong Kong, aiming to improve the quality of care of patients with SLE. More grants and funding are being sought for basic and clinical researches in SLE and subsidising patients to receive newer and less toxic treatment options.

Key Words: Chinese • epidemiology • morbidity • mortality • outcome • prevalence

Lupus, Vol. 12, No. 9, 717-722 (2003)
DOI: 10.1191/0961203303lu451xx


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. T. HIRAKI, S. M. BENSELER, P. N. TYRRELL, E. HARVEY, D. HEBERT, and E. D. SILVERMAN Ethnic Differences in Pediatric Systemic Lupus Erythematosus J Rheumatol, November 1, 2009; 36(11): 2539 - 2546. [Abstract] [Full Text] [PDF]

				W. Zhou and C. Yang The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients Lupus, August 1, 2009; 18(9): 807 - 812. [Abstract] [PDF]

				C. Pan, C. Wu, H. Chen, C. Dang, F. Chang, H. Liu, C. Chu, M Lin, and Y. Lee Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan Lupus, July 1, 2009; 18(8): 698 - 704. [Abstract] [PDF]

				W. Yang, M. Zhao, N. Hirankarn, C. S. Lau, C. C. Mok, T. M. Chan, R. W.S. Wong, K. W. Lee, M. Y. Mok, S. N. Wong, et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai Hum. Mol. Genet., June 1, 2009; 18(11): 2063 - 2070. [Abstract] [Full Text] [PDF]

				A. Al Arfaj and N Khalil Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia Lupus, April 1, 2009; 18(5): 465 - 473. [Abstract] [PDF]

				Q Shang, L. Tam, E. Li, G. Yip, and C. Yu Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus Lupus, December 1, 2008; 17(12): 1096 - 1102. [Abstract] [PDF]

				M. Nazarinia, F Ghaffarpasand, A Shamsdin, A. Karimi, N Abbasi, and A Amiri Systemic lupus erythematosus in the Fars Province of Iran Lupus, March 1, 2008; 17(3): 221 - 227. [Abstract] [PDF]

				H. Al-Rayes, R. Al-Swailem, M. Arfin, S. Sobki, S. Rizvi, and M. Tariq Lupus Around the World: Systemic lupus erythematosus and infections: a retrospective study in Saudis Lupus, September 1, 2007; 16(9): 755 - 763. [Abstract] [PDF]

				C S Lau, G Yin, and M Y Mok Ethnic and geographical differences in systemic lupus erythematosus: an overview Lupus, November 1, 2006; 15(11): 715 - 719. [Abstract] [PDF]

				Y Y Leung, K M Lo, L S Tam, C C Szeto, E K Li, and E W Kun Estimation of glomerular filtration rate in patients with systemic lupus erythematosus Lupus, May 1, 2006; 15(5): 276 - 281. [Abstract] [PDF]

				M Govoni, G Castellino, S Bosi, N Napoli, and F Trotta Incidence and prevalence of systemic lupus erythematosus in a district of North Italy Lupus, February 1, 2006; 15(2): 110 - 113. [Abstract] [PDF]

				C C Mok, A Mak, and K M Ma Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus Lupus, February 1, 2005; 14(2): 106 - 112. [Abstract] [PDF]

				J Albrecht, J A Berlin, I M Braverman, J P Callen, M I Costner, J Dutz, D Fivenson, A G Franks, J L Jorizzo, L A Lee, et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus Lupus, November 1, 2004; 13(11): 839 - 849. [Abstract] [PDF]

				M A Rabbani, B K Siddiqui, M H Tahir, B Ahmad, A Shamim, S M. Shah, and A Ahmad Systemic lupus erythematosus in Pakistan Lupus, October 1, 2004; 13(10): 820 - 825. [Abstract] [PDF]